HOXB3 and leukemia: In this manner, the researchers successfully identified a regulatory circuitry involving miR-375, HOXB3, and CDCA3/DNMT3B plays a significant role in the development of leukemia and also presents a potential therapeutic approach for AML by targeting the restoration of miR-375 expression [60].